AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $60.1 million versus the consensus estimate of $56.94 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.